| XYTOS INTRODUCES THEIR NEXT GENERATION CANCER TREATMENT AND DIAGNOSTIC PROCEDURE |
|
XYTOS, INC. NEWS RELEASE Trading Symbol: XYTS FOR IMMEDIATE DISSEMINATION
Imagine a future where a diagnosis of cancer is considered an inconvenience and not a life threatening disease. Imagine a future where cancer diagnostics and treatment are completely non-invasive and non-toxic. Imagine a future where cancer is detected as single cells, years before it becomes a detectable tumor. Imagine a future where the fear of testing for cancer is eliminated by the use of a completely non-invasive procedure. Imagine the possibility of transforming cancer from the # 1 killer of Americans under the age of 85, to a disease of the past. XYTOS is making these possibilities a reality. Tim Cook, Chairman and CEO of XYTOS, Inc., commented, "As I stated in an earlier news release, we have worked for many years positioning this company to become a global leader on the forefront of the next generation of medicine. We have quietly worked on our research and development for the past several years and we are now ready to introduce to the world Next Generation Bio-Medical Technologies. We are obviously very exited about the results that we have achieved with our Cancer Treatment and Diagnostic Procedure, and our treatment and diagnostic procedure will change the way cancer is perceived. We look forward to sharing the information with all interested readers, but because the details of the treatment are too extensive to disseminate in a news release we invite our investors as well as all interested parties to review the information on our website www.xytos.com to clearly see the results that we achieved over the past years. About XYTOS, Inc. XYTOS working at the forefront of the "Science of Medicine" is a Bio-Medical Technologies Company concentrating on the research, development and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering and Cellular Medicine. Forward-Looking and Cautionary Statements: Certain statements,, if any, contained herein, including, without limitation, statements containing the words "believes", "intends" and other words of similar import, constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of XYTOS, Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. XYTOS, Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Source: XYTOS, Inc. On behalf of the Board of Directors of: XYTOS INC. Tim Cook, CEO (Contact: info@xytos.com)
|